Performance of the HandScan in tight control treatment of Rheumatoid Arthritis

Performance of the HandScan in tight control treatment of Rheumatoid Arthritis - HandScan in rheumatoid arthritis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON47182

Enrollment

112

Registered

2015-01-14

Start date

2017-04-04

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

'Rheuma' Rheumatoid Arthritis

Interventions

HandScan guided treatment strategy

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Male or non-pregnant, non-nursing female >= 18 years of age Early RA patients, fulfilling 2010 ACR/EULAR criteria: Evidence of clinically apparent arthritis

Exclusion criteria

Exclusion criteria: Significant visual deformations of hands or fingers Rheumatic autoimmune disease other than RA Current inflammatory joint disease other than RA (e.g. gout, reactive arthritis, psoriatic arthritis, seronegative spondyloarthropathy, Lyme disease) Known porphyria (HandScan risk analysis). Contraindication for methotrexate or prednisolone Glucocorticoids used for RA

Design outcomes

Primary

Measure	Time frame
the Health Assessment Questionnaire (HAQ)	—

Secondary

Measure	Time frame
Cost-effectiveness Radiological damage Time until remission	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)